Ectopic pregnancy: a single-center experience over ten years

Reprod Biol Endocrinol. 2021 Jun 1;19(1):79. doi: 10.1186/s12958-021-00761-w.

Abstract

Purpose: The aim of this study was to investigate characteristics associated with ectopic pregnancy (EP) that could be utilized for predicting morbidity or mortality.

Methods: This was a retrospective analysis of pregnancy-related records from a tertiary center over a period of ten years. Data on age, gravidity, parity, EP risk, amenorrhea duration, abdominal pain presence and location, β-human chorionic gonadotropin (β-HCG) level, ultrasound findings, therapeutic intervention, exact EP implantation site and length of hospital stay (LOS) were obtained from the database. The LOS was used as a proxy for morbidity and was tested for an association with all variables. All statistical analyses were conducted with Stata® (ver. 16.1, Texas, USA).

Results: The incidence of EP in a cohort of 30,247 pregnancies over a ten-year period was 1.05%. Patients presented with lower abdominal pain in 87.9% of cases, and the likelihood of experiencing pain was tenfold higher if fluid was detectable in the pouch of Douglas. Only 5.1% of patients had a detectable embryonic heartbeat, and 18.15% had one or more risk factors for EP. While most EPs were tubal, 2% were ovarian. The LOS was 1.9 days, and laparoscopic intervention was the main management procedure. The cohort included one genetically proven dizygotic heterotopic pregnancy (incidence, 3.3 × 10- 5) that was diagnosed in the 7th gestational week. The only association found was between the β-HCG level and LOS, with a linear regression β coefficient of 0.01 and a P-value of 0.04.

Conclusion: EP is a relatively common condition affecting approximately 1% of all pregnancies. β-HCG correlates with EP-related morbidity, but the overall morbidity rate of EP is low regardless of the implantation site. Laparoscopic surgery is an effective therapeutic procedure that is safe for managing EP, even in cases of heterotopic pregnancy.

Keywords: Dizygotic ectopic; Ectopic pregnancy; Heterotopic pregnancy; β-HCG.

MeSH terms

  • Abdominal Pain / physiopathology*
  • Abortifacient Agents, Nonsteroidal / therapeutic use
  • Adult
  • Cesarean Section / statistics & numerical data
  • Chorionic Gonadotropin, beta Subunit, Human / blood*
  • Douglas' Pouch
  • Female
  • Humans
  • Incidence
  • Intrauterine Devices
  • Laparoscopy
  • Length of Stay / statistics & numerical data*
  • Methotrexate / therapeutic use
  • Middle Aged
  • Pregnancy
  • Pregnancy, Ectopic / blood
  • Pregnancy, Ectopic / epidemiology*
  • Pregnancy, Ectopic / physiopathology
  • Pregnancy, Ectopic / therapy
  • Pregnancy, Heterotopic / blood
  • Pregnancy, Heterotopic / epidemiology
  • Pregnancy, Heterotopic / physiopathology
  • Pregnancy, Heterotopic / therapy
  • Pregnancy, Ovarian / blood
  • Pregnancy, Ovarian / epidemiology
  • Pregnancy, Ovarian / physiopathology
  • Pregnancy, Ovarian / therapy
  • Pregnancy, Tubal / blood
  • Pregnancy, Tubal / epidemiology
  • Pregnancy, Tubal / physiopathology
  • Pregnancy, Tubal / therapy
  • Reproductive Techniques, Assisted / statistics & numerical data
  • Retrospective Studies
  • Risk Factors
  • Salpingectomy
  • Salpingostomy
  • Smoking / epidemiology
  • Young Adult

Substances

  • Abortifacient Agents, Nonsteroidal
  • Chorionic Gonadotropin, beta Subunit, Human
  • Methotrexate